Monocyte/Macrophages as Effector Cells in Cancer Immunotherapy

By Oberling F.  

Transfusion Science, Vol. 18, Iss. 2, 1997-06 ,pp. : 243-250

Elsevier

Access to resources Recommend Favorite

Macrophages as an effector mechanism to reject encapsulated hepatoma cells

By Yu S.-C.   Chen J.-P.   Liu H.-S.   Hsu B.R.-S.   Fu S.-H.  

Transplantation Proceedings, Vol. 32, Iss. 5, 2000-08 ,pp. : 958-959

Elsevier

Access to resources Recommend Favorite

Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapies

By Kalinski Pawel   Muthuswamy Ravikumar   Urban Julie  

Expert Review of Vaccines, Vol. 12, Iss. 3, 2013-03 ,pp. : 285-295

Informa Healthcare

Access to resources Recommend Favorite

Antigen Delivery to Dendritic Cells: Implications for Cancer Immunotherapy

By Nayak J.V.   Falo L.D.  

Clinical Immunology Newsletter, Vol. 19, Iss. 10, 1999-10 ,pp. : 131-135

Elsevier

Access to resources Recommend Favorite

Optimizing Tumor-Reactive &ggr;&dgr;T Cells for Antibody-Based Cancer Immunotherapy

By  

Current Molecular Medicine, Vol. 10, Iss. 8, 2010-11 ,pp. : 719-726

Bentham Science Publishers

Access to resources Recommend Favorite